2006 VFC Letters

• Quadrivalent Human Papillomavirus (HPV) Recombinant
  Vaccine is Now Available from VFC  - December 4
  Vaccine usage recommendations, disease information and more.

• Resumption of Immunization of 11-12 Year Olds with
  Meningococcal Conjugate Vaccine (MCV4) - November 22
  (Menactra®, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania)

• Letter to California Physicians from the State Public Health Officer - November 2
  Use of Thimerosal-containing Influenza Vaccine In Children Younger Than 3 Years of Age.

• Influenza Season 2006–2007 Mailing to VFC Providers - September 18
  The above document contains the entire mailing, including letter, order form, instructions, VISes, and a list of available products. These documents are also available individually.

• VFC Covers Second Dose of Varicella - August 11
  The VFC program now covers both the first and second dose of varicella-containing vaccine, administered either as single-antigen varicella vaccine (VZV; Varivax®) or combined measles, mumps, rubella, and varicella vaccine (MMRV; Proquad®).

• Prevention of Perinatal Hepatitis B Transmission - July 24
  Contains updated recommendations for hepatitis B immunization of infants. Other materials related to this VFC letter (PDF format)
   

• Updated Mumps Immunization Recommendations - June 22
  Contains revised immunization recommendations in response to the large mumps outbreak primarily affecting Midwestern states.
   

• Decreased Availability of Meningococcal Conjugate Vaccine (MCV-4) - June 8
  Contains temporary amended guidelines for the administration of Meningococcal Conjugate Vaccine (MCV-4)
   

• Rotavirus Vaccine Now Available - June 15
  A collection of documents such as an official Immunization Branch letter, a vaccine information statement, and a Vaccines for Children order form.
   

• Tdap: A New Era - May 17
  Contains information about and recommendations for Tdap in preteens and teenagers.
   

• Annual Public Sector Vaccines for Children (VFC) Recertification - March 1
   

• Combined Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine - February  28
  Proquad, the live, attenuated measles, mumps, rubella, and varicella (MMRV) vaccine, has the potential of reducing the number of injections needed for routine childhood vaccination.
   

• Recommendations for the Use of Tdap in Older Children - January 30
  Information about what are, and what are not true contraindications to DTaP in children.
   

• Hepatitis A Recommendations - January 30
  A letter explaining the increase in Hepatitis A coverage from two years of age down to one year of age.
   

• Flu Vaccine and Thimerosal - January 19
  Information about the limits placed on vaccinating pregnant women and children younger than 3.